Share

EORTC QLG Executive Committee – Call for Candidates

Dear EORTC QLG active members,

During the Cyprus meeting in April (28th & 29th), the terms of Secretary Karin Kuljanic and PMDC Co-Lead Sally Wheelwright will come to an end on the EORTC Quality-of-Life Group Executive Committee.

If you are interested please see  role specifications for more information about the Secretary or PMDC Co-Lead position.

The call for candidates will open on Tuesday 8th March and the deadline to submit your name will be Wednesday 23rd March.

Voting will be open as of Friday 25th March and will be open for two weeks with the deadline to submit your vote on Friday 8th April.

If you would like to put your name forward for the open position of either the Secretary or PMDC Co-Lead position, please provide the following information:

  • One page CV
  • Short motivation statement
  • Names of two QLG active members that support your candidacy (these cannot be members on the Executive Committee)

Please send this information to Amy Thomas (Chair Assistant) chair.eortcqlg@soton.ac.uk

 

Back to news list

Related News

  • New study validates clustering of QLQ-30 HRQoL scales, which can help symptom burden management and inform clinical trial design 

  • EORTC Quality of Life Group Open Access Policy

  • New QLG publication “Developing an e-learning course on the use of PRO measures in oncological practice: health care professionals’ preferences for learning content and methods”

  • “Psychometric validation of the European Organisation for Research and Treatment of Cancer–Quality of Life Questionnaire Sexual Health (EORTC QLQ-SH22)”

  • “Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors”

  • “Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial”

  • “Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients”

  • “Minimally important differences for interpreting the EORTC QLQ-C30 in advanced colorectal cancer patients treated with chemotherapy”

  • UPDATE – 17-18 September 2020 Quality of Life Group Virtual Autumn meeting